66 results
Page 2 of 4
8-K
EX-99.1
xbthbb
2 Mar 21
Regulation FD Disclosure
8:00am
8-K
EX-99.2
kgky7u0ia9hsbpn7ljf7
19 Nov 20
Aravive Announces Phase 3 Trial Design for AVB-500 in Platinum Resistant Ovarian Cancer
7:10am
8-K
EX-99.1
mpql46mje5hf9 myw
8 Oct 20
Regulation FD Disclosure
5:01pm
8-K
EX-1.1
b3z4u26djg
27 Nov 19
Aravive Announces Proposed Public Offering of Common Stock
4:15pm
424B5
eo7lxxo9t5
27 Nov 19
Prospectus supplement for primary offering
4:07pm
424B5
pbdmfd mafuvp2
26 Nov 19
Prospectus supplement for primary offering
5:18pm
424B5
7j7u9ltimnr2odzb2
26 Mar 19
Prospectus supplement for primary offering
6:25am
8-K
EX-1.1
xny9d2e8o0dervq8
26 Mar 19
Entry into a Material Definitive Agreement
6:07am
S-4
1tb5n7na 2f4
3 Aug 18
Registration of securities issued in business combination transactions
5:26pm